LYCA Stock: Price, Earnings History and SEC Filings
Lycia Therapeutics, Inc. (LYCA) last traded at $26.40, down 4.80% on the latest session and down 12.0% over the past month.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LYCA earnings history
Earnings history is not available right now.
Latest SEC filings for LYCA
Insider filing activity
LYCA insiders filed 11 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
LYCA news
- Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesOct 26, 2026 · finance.yahoo.com
- Lycia Therapeutics (LYCA) Jumps After IPO With Valuation Questions Now Front And CenterOct 26, 2026 · finance.yahoo.com
- Forget Anthropic: Biotech Is Quietly Dominating the IPO SphereOct 24, 2026 · finance.yahoo.com
- Lycia Therapeutics surges in debut following upsized $317.5M IPOOct 23, 2026 · finance.yahoo.com
About Lycia Therapeutics, Inc.
Lycia Therapeutics, Inc. (LYCA) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in DE. Its fiscal year ends in December.